Highlights
A collection of news and information related to Lilly Eli & Co published by this site and its partners.
Displaying items 1-12 of 205
» View wsbtradio.com items only
1
2
3
4
5
6
7
8
9
10
11-18
•
Next >
-
ANALYSIS-Amazon gets help to lure big business to the cloud
Reuters(Repeats with no changes to text or headline) * Amazon has built up network of more than 4,000 cloud partners * Partners help satisfy more demanding enterprise customers * Crucial as Amazon targets $300 billion market By Alistair Barr SAN FRANCISCO,...Tags: E-Commerce Industry, Amazon.com Inc., Computing and Information Technology Industry, Marketing, Business
-
Analysis: Amazon gets help to lure big business to the cloud
ReutersSAN FRANCISCO (Reuters) - As Amazon.com Inc seeks to transform itself into a leading provider of technology to the world's largest corporations, it's discovering that it needs help. The online retailer, which since 2006 has moved aggressively into the...Tags: E-Commerce Industry, Amazon.com Inc., Computing and Information Technology Industry, Marketing, Business
-
Lilly CEO recovering after repair to aorta
ReutersMay 14 (Reuters) - John Lechleiter, the longtime chief executive of Eli Lilly and Co, is recovering from successful surgery to repair a dilated aorta, the U.S. drugmaker said on Tuesday. "Dr. Lechleiter is recovering and will be closely monitored by...Tags: Medical Procedures and Tests, Companies and Corporations, Economy, Business and Finance, Corporate Officers
-
U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group
ReutersMay 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...Tags: Entertainment, Nelnet Incorporated, Petroleum Industry, Penn National Gaming, Economy, Business and Finance
-
Eli Lilly's lymphoma drug fails in late-stage trial
ReutersMay 10 (Reuters) - Eli Lilly and Co said it will stop developing its experimental cancer drug after a late-stage trial failed to show a statistically significant increase in patients' disease-free survival. The drug, enzastaurin, was being tested in...Tags: Chemotherapy, Lymphoma, Health Treatments, Cancer
-
Doctor-drug company database adds to confusion for consumers
Last week, after the launch of a new database detailing doctors' financial ties with drug companies, Dr. Daniel Carlat sat at his computer and began searching for information about colleagues.
He found several doctors who had potentially compromising...Tags: Cephalon Incorporated, Yale University, Hospitals and Clinics, Merck & Company Incorporated, General Practitioners
-
REUTERS SUMMIT-Novo's long-term targets hinge on two drugs -CEO
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Danish group under pressure after U.S. Tresiba setback * CEO says obesity drug could keep profit goals on track * Novo expects liraglutide for obesity to...Tags: Obesity, Medical Research, Body Mass Index, Food and Drug Administration, New Products
-
Lilly CEO Lechleiter to undergo surgery for dilated aorta
ReutersMay 6 (Reuters) - Drug maker Eli Lilly and Co said Chief Executive John Lechleiter will undergo a surgery on May 13 to treat a dilated aorta but is expected to recover and return to work by this summer. Chief Financial Officer Derica Rice will serve as...Tags: Symptoms, Companies and Corporations, Swelling, Economy, Business and Finance, Corporate Officers
-
February 26, 2002: Bowen lends voice to look at Reagan
BREMEN -- Dr. Otis R. Bowen, who celebrates his 84th birthday today, is already a permanent fixture in his hometown of Bremen, but later this year, he'll also become a permanent fixture in the Ronald Reagan library and museum. As a former Indiana...Tags: Medical Procedures and Tests, Notre Dame Fighting Irish, University of Virginia, Ronald Reagan, Executive Branch
-
Lilly broadens diabetes offer with eye on bigger slice of booming market
Reuters* Head of diabetes says eyeing broadest portfolio in industry * Aiming to win bigger slice of growing market * Lilly currently No.4 in $40 bln diabetes market * Lilly says mainly addressing GPs, not specialists By Ludwig Burger and Frank Siebelt...Tags: France, Bristol Myers Squibb Company, Chemical Industry, Pharmaceuticals, Diabetes
-
Eli Lilly amplía oferta en diabetes para reforzar presencia en mercado
ReutersPor Ludwig Burger y Frank Siebelt FRANCFORT (Reuters) - Eli Lilly, el cuarto fabricante mundial de medicamentos para la diabetes, buscará tener la variedad más amplia posible de fármacos antidiabéticos con el fin de ganar una mayor porción de ese...Tags: Merck & Company Incorporated, Bristol Myers Squibb Company, Byetta (drug), Diabetes, Januvia (drug)
-
Veeva Systems planning initial public offering - sources
ReutersBy Olivia Oran April 30 (Reuters) - Life sciences-focused software company Veeva Systems is planning an initial public offering that could come in the third quarter and has selected banks to lead the deal, according to two people familiar with the...Tags: Financing and Stock Offerings, Chemical Industry, Pharmaceuticals, Computing and Information Technology Industry, Deutsche Bank AG
May 15, 2013
|Story| Reuters
May 14, 2013
|Story| Reuters
May 14, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 10, 2013
|Story| Reuters
Oct 28, 2010
|Story| Chicago Tribune
May 7, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
May 5, 2013
|Story| South Bend Tribune
May 3, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
Apr 30, 2013
|Story| Reuters
Original site for Lilly Eli & Co topic gallery.